[BHVN] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[BHVN] Biohaven Pharmaceutical Holding Company Ltd.
Announcement Date
09-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 66.13%
YoY- -26.65%
Quarter Report
BHVN's Result
BHVN's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 -215,079 0 215,079 318,852 190,013 -
PBT -88,169 -69,553 -215,250 -67,637 -197,177 -89,777 -49,429 47.23%
Tax 2,177 939 -14,143 1,216 6,110 7,255 2,457 -7.76%
NP -90,346 -70,492 -201,107 -68,853 -203,287 -97,032 -51,886 44.88%
Tax Rate - - - - - - - -
Total Cost 90,346 70,492 -13,972 68,853 418,366 415,884 241,899 -48.23%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 93.50 0.00 -94.52 -30.43 -27.31 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.32 -1.03 -3.30 -1.75 -5.67 -2.71 -1.45 -6.08%
EPS Diluted -1.32 -1.03 -3.30 -1.75 -5.67 -2.71 -1.45 -6.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.